Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Glioma × avelumab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Ovarian Neoplasms 5 Neoplasm Metastasis 5 Carcinoma, Transitional Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Carcinoma, Renal Cell 4 Triple Negative Breast Neoplasms 3 Breast Neoplasms 3 Recurrence 2 Lymphoma 2 Colorectal Neoplasms 2 Central Nervous System Neoplasms 2 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Skin Neoplasms 1 Sezary Syndrome 1 Sarcoma 1 Prostatic Neoplasms 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Mycosis Fungoides 1 Metastatic Urothelial Cell Cancer 1 Metastatic Solid Tumors 1 Meningioma 1 Meningeal Neoplasms 1 Meningeal Carcinomatosis 1 Melanoma 1 Malignant Solid Tumour 1

Interventions

Temozolomide 39 Radiotherapy 13 Magnetic Resonance Spectroscopy 9 Bevacizumab 8 Surgical Procedures, Operative 7 Irinotecan 7 Radiation 6 Carboplatin 6 ribociclib 5 Specimen Handling 5 Radiosurgery 5 Nivolumab 5 Imiquimod 5 Flucytosine 5 Filgrastim 5 Erlotinib Hydrochloride 5 Carmustine 5 Aminolevulinic Acid 5 vandetanib 4 sargramostim 4 Topotecan 4 O(6)-benzylguanine 4 Imatinib Mesylate 4 IL13-PE38 4 Etoposide 4 Cyclophosphamide 4 Craniotomy 4 vocimagene amiretrorepvec 3 lentiviral minigene vaccine of COVID-19 coronavirus 3 Thiotepa 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03893903 2025-03-14

AMPLIFY-NEOVAC

German Cancer Research Center

Phase 1 Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡